News tagged with antiplatelet therapy

Related topics: clopidogrel , patients , coronary intervention , thrombosis , myocardial infarction




Results of the EVOLVE trial reported at TCT 2011

A clinical trial has established the non-inferiority of a drug-eluting stent with a bioabsorbable polymer compared to a drug-eluting stent with a durable polymer. Results of the EVOLVE clinical trial were presented today ...

Cardiology created Nov 11, 2011 | popularity not rated yet | comments 0

Results of the PARIS registry Reported at TCT 2011

Non-adherence to antiplatelet therapy – which prevents blood clots following percutaneous coronary intervention (PCI) – was associated with higher rates of both ischemic and bleeding events at 30 days. Results of ...

Cardiology created Nov 09, 2011 | popularity not rated yet | comments 0

30-day results of ADAPT-DES registry reported at TCT 2011

The relationship of platelet responsiveness to antiplatelet medications; and, the correlation of poor response, and overall platelet aggregation while on dual antiplatelet therapy to the risk of drug-eluting stent thrombosis ...

Cardiology created Nov 09, 2011 | popularity not rated yet | comments 0

Results of the DESERT registry reported at TCT 2011

The risk of late stent thrombosis (ST) in the first generation of drug-eluting stents continues for up to seven years after implantation, and certain types of patients, including smokers and those who are younger, are at ...

Cardiology created Nov 09, 2011 | popularity not rated yet | comments 0

Safety and tolerability of the oral Xa inhibitor darexaban for secondary prevention after acute coronary syndromes

A phase II dose-finding study has found that the new oral Factor Xa inhibitor darexaban was associated with a two to four-fold increase in bleeding when added to dual antiplatelet therapy in patients following an acute coronary ...

Cardiology created Aug 30, 2011 | popularity not rated yet | comments 0

Assessing the most appropriate duration of dual antiplatelet therapy after coronary stenting

A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months ...

Cardiology created Aug 30, 2011 | popularity not rated yet | comments 0


  • Pages: 1 2